博士

主治医师

博士期间对妇科肿瘤的发病机制和治疗进行了深入的研究。擅长宫颈癌前病变、宫颈癌、阴道疾病、子宫肌瘤、子宫腺肌症的诊断与治疗。

Meiying Zhang#, Guanglei Zhuang#, Xiangjun Sun, Wen Di, et al. TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer. Diagnostic Pathology. 2017, 12:16. Shengzhe Zhang#, Ying Jing#, Meiying Zhang#, Guanglei Zhuang, et al. Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer. Scientific Reports. 2015, 5:16066.(co-first author) Meiying Zhang#, Guanglei Zhuang, Wen Di, et al. Risk prediction model for epithelial ovarian cancer using molecular markers and clinical characteristics. Journal of Ovarian Research. 2015, 8:67. Yi-feng He#, Mei-ying Zhang#, Di Wen,et al.High MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival time.Plos one.2013,8:e79769.(co-first author) Mei-ying Zhang#, Di Wen,et al.A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients.Journal of Ovarian Research.2014,7:19

2015/08-2016/08，加拿大渥太华大学附属渥太华医院研究所，访问学者 2012/09-2015/06，上海交通大学，妇产科，博士，导师：狄文 2006/09-2008/06，上海交通大学，临床医学，硕士,导师：狄文 2001/09-2006/06，上海交通大学，临床医学，本科